Search Results - "Martín Carbonero, Luz"
-
1
48-Week effectiveness and tolerability of dolutegravir (DTG) + lamivudine (3TC) in antiretroviral-naïve adults living with HIV: A multicenter real-life cohort
Published in PloS one (01-11-2022)“…The main international guidelines indicate DTG/3TC therapy as one of the preferred regimens for people living with HIV (PLWH), due to its observed efficacy in…”
Get full text
Journal Article -
2
Rilpivirine Activates STAT1 in Non-Parenchymal Cells to Regulate Liver Injury in People Living with HIV and MASLD
Published in Biomedicines (29-06-2024)“…Liver fibrosis is a key determinant of the progression of metabolic dysfunction-associated steatotic liver disease (MASLD). Its increasing prevalence and a…”
Get full text
Journal Article -
3
Incidence and Predictors of Severe Liver Fibrosis in Human Immunodeficiency Virus—Infected Patients with Chronic Hepatitis C: A European Collaborative Study
Published in Clinical infectious diseases (01-01-2004)“…A study was performed in 10 European health care centers in which 914 patients coinfected with hepatitis C virus (HCV) and human immunodeficiency virus (HIV)…”
Get full text
Journal Article -
4
Rate and Timing of Hepatitis C Virus Relapse after a Successful Course of Pegylated Interferon plus Ribavirin in HIV-Infected and HIV-Uninfected Patients
Published in Clinical infectious diseases (01-11-2009)“…Information on the rate and timing of hepatitis C virus (HCV) relapse after treatment with pegylated interferon plus ribavirin is scarce. Among 604 patients…”
Get full text
Journal Article -
5
Early monitoring of ribavirin plasma concentrations may predict anemia and early virologic response in HIV/hepatitis C virus-coinfected patients
Published in Journal of acquired immune deficiency syndromes (1999) (01-08-2005)“…Ribavirin (RBV) in combination with pegylated interferon alpha (pegIFN) is currently the standard treatment of hepatitis C virus (HCV) infection. The…”
Get full text
Journal Article -
6
Development and validation of a new and rapid molecular diagnostic tool based on RT-LAMP for Hepatitis C virus detection at point-of-care
Published in Methods (San Diego, Calif.) (01-12-2024)“…[Display omitted] •HCV underdiagnosis among hard-to-reach population is still of concern.•Our new RT-LAMP system detects HCV RNA directly from lysed…”
Get full text
Journal Article -
7
Predictors of Liver Fibrosis in HIV-Infected Patients with Chronic Hepatitis C Virus (HCV) Infection: Assessment Using Transient Elastometry and the Role of HCV Genotype 3
Published in Clinical infectious diseases (01-04-2006)“…Background. Liver fibrosis is accelerated in patients coinfected with hepatitis C virus (HCV) and human immunodeficiency virus (HIV). The reasons for this…”
Get full text
Journal Article -
8
Rate of hepatitis C reinfection after successful direct-acting antivirals treatment among people who inject drugs in Spain: the LIVERate study
Published in BMC public health (14-11-2024)“…Background Hepatitis C virus (HCV) reinfection following successful treatment threatens the achievement of HCV elimination. The primary aim of this study is to…”
Get full text
Journal Article -
9
Chronic Hepatitis E in HIV Patients: Rapid Progression to Cirrhosis and Response to Oral Ribavirin
Published in Clinical infectious diseases (01-08-2013)“…Chronic hepatitis E virus infection with rapid progression to cirrhosis is reported in 2 human immunodeficiency virus (HIV)—infected patients with severe…”
Get full text
Journal Article -
10
Sex differences in the effectiveness and tolerability of dolutegravir plus rilpivirine as a switch strategy in people living with HIV
Published in HIV medicine (01-06-2024)“…Introduction Dolutegravir + rilpivirine (DTG + RPV) is an effective antiretroviral therapy regimen approved in clinical guidelines as a switch therapy for…”
Get full text
Journal Article -
11
Persistent low-Level viremia in persons living with HIV undertreatment: An unresolved status
Published in Virulence (31-12-2021)“…Antiretroviral therapy (ART) allows suppressed viremia to reach less than 50 copies/mL in most treated persons living with HIV (PLWH). However, the existence…”
Get full text
Journal Article -
12
HCV spontaneous clearers showed low senescence profile in people living with HIV under long ART
Published in Journal of medical virology (01-07-2023)“…Coinfection with hepatitis C virus (HCV) and human immunodeficiency virus (HIV) increases immune activation, inflammation, and oxidative stress that could lead…”
Get full text
Journal Article -
13
Hepatocellular carcinoma risk in hepatitis C stage‐3 fibrosis after sustained virological response with direct‐acting antivirals
Published in Liver international (01-12-2021)“…Background & Aims Patients with chronic hepatitis C and stage 3 fibrosis are thought to remain at risk of hepatocellular carcinoma after sustained virological…”
Get full text
Journal Article -
14
Hepatitis B virus and HIV infection
Published in Seminars in liver disease (01-05-2012)“…Approximately 5 to 10% of human immunodeficiency virus- (HIV-) infected persons worldwide have chronic hepatitis B virus (HBV). The management of these…”
Get more information
Journal Article -
15
903 Protein Saver cards: the best alternative for dried blood spot storage at room temperature for HCV RNA
Published in Scientific reports (16-06-2022)“…Hepatitis C virus (HCV) infection remains a global health problem, detected only in the early stages by molecular tests. Molecular tests detect HCV RNA, which…”
Get full text
Journal Article -
16
Mortality Due to Chronic Viral Liver Disease among Patients Infected with Human Immunodeficiency Virus
Published in Clinical infectious diseases (15-11-2001)Get full text
Journal Article -
17
P-8 EXTRACELLULAR VESICLE-DERIVED MICRORNA SIGNATURE IN HCV AND HCV/HIV PATIENTS WITH DIFFERENT STAGES OF LIVER FIBROSIS
Published in Annals of hepatology (01-03-2023)“…Extracellular vesicles (EVs) are essential players in cell communication, and their cargo modulates the receptor cell response. MicroRNAs (miRNAs) proved to…”
Get full text
Journal Article -
18
Impact of Nucleos(t)ide Reverse Transcriptase Inhibitors on Blood Telomere Length Changes in a Prospective Cohort of Aviremic HIV-Infected Adults
Published in The Journal of infectious diseases (05-10-2018)“…Tenofovir is a potent inhibitor of human telomerase. The clinical relevance of this inhibition is unknown. A prospective cohort of human immunodeficiency virus…”
Get full text
Journal Article -
19
Change in metabolic parameters after switching from triple regimens with tenofovir alafenamide to dolutegravir‐based dual therapy. Bi‐lipid study
Published in HIV medicine (01-05-2023)“…Introduction The use of tenofovir alafenamide (TAF) has been associated with increased cholesterol and body weight. Real‐life data on the metabolic effects of…”
Get full text
Journal Article -
20
Metabolic effects of switching to Biktarvy (B/F/TAF) in patients with HIV‐1 treated with antiretroviral regimens that do not include tenofovir disoproxil fumarate (TDF) or tenofovir alafenamide (TAF): The Metabic study
Published in HIV medicine (01-09-2024)“…Background Studies on switching to tenofovir alafenamide (TAF)‐based regimens raise concerns about a worse metabolic profile in people with HIV, even though…”
Get full text
Journal Article